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Background and Objectives. The purpose of the study is to determine the ideal concentra­
tion of morphine when given with bupivacaine as a continuous high thoracic epidural 
infusion for postthoracotomy pain. Methods. In a prospective study, 60 patients sched­
uled for thoracic surgery received a high thoracic epidural catheter. Postoperative 
analgesia was provided by a continuous epidural infusion for 3 days. The patients 
were randomly divided into two groups: group 1 (loading dose 1 mg morphine epidur- 
ally and continuous infusion of bupivacaine 0.75% + 0.2 mg/mL morphine at an 
infusion rate of 0.8 mL/hr); group 2 (loading dose 0.5 mg morphine epidurally and 
continuous infusion of bupivacaine 0,75% + 0.1 mg/mL morphine at an infusion rate 
of 0.8 mL/hr). Results. The visual analog scales were not different at rest but with 
exercise in group 1 there was better pain relief than in group 2. The number of patients 
requiring supplementation of analgesia in group 2 (n = 42) was six times that of 
group 1 (n = 7). PaC02 increased in both groups during the first postoperative day. 
There was no difference in the incidence of side effects between the two groups. 
Conclusions. Continuous high thoracic epidural administration 0.2 mg/mL morphine 
in bupivacaine 0.75% at an infusion rate of 0.8 mL/hr with a loading dose of 1 mg 
morphine is an effective dose for postthoracotomy pain relief in rest, and more impor­
tant, during exercise. Reg Anesth Î995: 20; 27-32.
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Pain after thoracic surgery is associated with shal­
low breathing and inability to cough effectively. 
Some of the known relationships between pain and 
pulmonary function indicate the development of a 
restrictive pattern of ventilation with reduced lung 
compliance.1 An important part of postthoracotomy 
pain treatment should be that the patient is able to 
take deep expansive breaths, cough effectively to 
clear airways, and cooperate with physiotherapy.1
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The combination of thoracic epidural anesthesia 
and light general anesthesia, followed by postopera­
tive epidural analgesia, has been advocated for tho­
racic surgery in order to provide stable intraoperative 
haemodynamics and effective postoperative pain re­
lief.2' 3 Epidural administration of the combination 
of local anesthetics and opioids is an effective method 
for postoperative pain relief.2,4-6 Previous studies 
have shown that epidural administration of mor­
phine provides good pain relief after thoracotomy 
with a minimum of side effects.7“" 12 
Morphine, a widely available and inexpensive opi­
oid, is still the gold standard to which other opioids 
are compared. Because of the fear for late respiratory
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depression, there are only a few studies regarding 
continuous morphine administration in combination 
with a local anesthetic through a high thoracic epi­
dural catheter.8,9,13
Most studies of morphine for postoperative pain 
relief used a lumbar epidural catheter for continuous 
infusion or intermittent bolus injection,7'9-11 since 
respiratory depression from epidural morphine is as­
sociated with higher vertebral levels of administra­
tion .14 The aim of this prospective study was to 
evaluate in a randomized double-blind manner two 
different doses of morphine in combination with 
bupivacaine used in high thoracic continuous epi­
dural infusion.
Materials and Methods
After informed consent and approval by the hospi­
tal ethics committee, 60 patients (ASA class 2 to 4) 
scheduled for thoracic surgery were randomly di­
vided by into two groups. All patients underwent a 
lateral thoracotomy by the same surgeon.
All patients received oral diazepam 10 mg, I hour 
before surgery. An intravenous infusion was estab­
lished with a 16 gauge catheter, and a 20-gauge ra­
dial arterial catheter was inserted to allow continu­
ous blood pressure monitoring and arterial sampling 
blood for blood gas analysis. The epidural catheter 
was introduced with the patient awake in the sitting 
position just before surgery. A 16-gauge Tuohy 
needle was inserted, using a paramedian approach 
at the T3—T4 or T4-T5 level. The hanging drop tech­
nique was used to indicate the entry point of the 
needle into the epidural space. The needle opening 
was directed cephalad and a catheter was inserted 4 
cm, A test dose of 3 mL lidocaine 2% with epineph­
rine was given. The patient was then turned into the 
supine position and sensory block was assessed by 
response to pinprick 10 minutes later. When bilateral 
sensory analgesia had been demonstrated, 1 mg mor­
phine (group 1) or 0.5 mg morphine (group 2) was 
injected epidurally, followed by bupivacaine 0.5% 
with epinephrine 5 /xg/mL 6-8 mL, depending on 
the size of the patient and extension of the block 
after the test dose. Immediately thereafter, general 
anesthesia was induced with intravenous thiopental 
5-7 mg/kg, followed by pancuronium 0.1 mg/kg and 
fentanyl 0.1 mg. After tracheal intubation, anesthesia 
was maintained with 0.3%—0.5% halothane and a 
N20/02 mixture in a ratio of 1:1. The patients' lungs 
were ventilated to keep the end tidal pC02 between 
33 (mmHg) and 36 (mm Hg) kPa. Epidural anesthe­
sia during and after surgery was administered as 
follows:
group 1 (n ~ 30): bupivacaine 0.75% with mor­
phine 0.2 mg/mL by continuous infusion at 0.8 
mL/hr for 3 days, 
group 2 (n = 30): bupivacaine 0.75% with mor­
phine 0.1 mg/mL by continuous infusion at 0.3 
mL/hr for 3 days.
The infusion was labeled study drug. At surgery com­
pletion, all patients were allowed to resume sponta­
neous breathing, were extubated, and transferred to 
an adjacent intermediate care unit, where they re­
mained under constant observation for 3 days.
Measured Variables
Blood-gas estimations were made the day before 
surgery, the day of surgery (day 1), and on the first 
and second day after surgery (days 2 and 3) at fixed 
times. During the study, respiration rate was moni­
tored and arterial pressure and electrocardiogram 
were monitored continuously. If the respiration rate 
fell below 14/min or the previous arterial blood gas 
analysis demonstrated substantial (> 10%) increase 
of PaC02, additional blood samples were taken.
Postoperative Pain Relief
Neither the patient nor the physician evaluator 
knew which concentration of morphine was being 
infused. Pain was evaluated every hour using the vis­
ual analog scale (VAS), where 0 indicates no pain 
{optimal pain relief) and 10 indicates the most severe 
pain (no pain relief). To confirm the effectiveness 
of analgesic treatment, patients were asked whether 
they suffered pain during deep expansive breathing, 
coughing, or physiotherapy. Whenever postopera­
tive pain was experienced, a bolus dose 0.8 mL of 
the running infusion was administered epidurally.
Side Effects
The incidence of side effects (nausea, vomiting, 
pruritis, and somnolence) were recorded. Urinary re­
tention was not registered because all patients had 
urinary bladder catheter.
Data Analysis
Statistical analysis of the data was performed using 
ANOVA or repeated measures MANOVA, two-tailed 
Fisher's exact test, Student's ¿-test, and the Wil- 
coxon's two-sample test, using the SAS statistical 
package. Values of P <  .05 were considered signifi­
cant. Data are expressed as mean values ±SD.
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Table 1. Demographic Data
Group 1 (SD) Group 2 (SD)
Number 30 30
Male/Female 25/5 23/7
Age (years) 58.1 (14.9) 57.9 (10.8)
Weight (kg) 73.3 (10.6) 73.0 (11.1)
Height (cm) 173.1 (6.5) 172.1 (7.9)
COPD (n) 12 11
PaC02 (kPa) 40.65(4.35)* 37.65(3.75)*
Group 1; high dose morphine; group 2: low dose morphine. 
*P < .05 (Wilcoxon's two-sample test).
Table 2. Number of Patients Requiring 





n = 30 P*
day 1 2 17 < .0 0 1
day 2 3 16 <.05
day 3 2 9 < .0 0 1
Group 1: high dose morphine; group 2: low dose morphine. 
* Two-tailed Fisher's exact test.
Results
Demographic Data
Sixty patients completed this study, 30 patients in 
group 1 and 30 patients in group 2 . There were no 
differences in demographic data between the two 
groups except the preoperative PaC02 in group 1 was 
higher than in group 2, P <  .05 (Table 1).
Postoperative Pain Relief
During the 3 days of investigation, all VAS scores 
remained below the mean level of 3. Between both 
groups, a significant difference could be demon­
strated; group 2 had higher VAS scores than group 
1 (Fig. 1). In both groups patients asked for addi­
tional pain relief that was accomplished by adminis­
tering extra bolus doses. On the first day, two patients 
of group 1 and 17 patients of group 2 were given
extra bolus doses. On the second day, three patients 
of group 1 and 16 patients of group 2 were given 
extra bolus doses. On the third day, two and nine 
patients, respectively, were given extra bolus doses 
(Table 2 ). Several patients in group 2 had pain on 
deep breathing compared to zero patients in group 
1. Also, a statistically significant number of patients 
in group 2 had pain on coughing and during physio­
therapy on days 1 and 2 (Table 3).
Ventilatory Variables
Postoperative respiratory data are shown in Fig­
ures 2 and 3. The mean postoperative PaC02 was 
higher in group 1 than in group 2 , but there was no 
statistical difference in mean PaC02 at any time. The 
mean PaC02 on day 1 in both groups was signifi­
cantly increased compared to the preoperative value, 
but there was no difference in increase in PaC02 be­
tween group 1 and 2 . On days 2 and 3, there was
10
Fig. 1. Visual analog scale 
scores (±SEM) for postopera­
tive pain relief in both groups, 
plotted against time (hours), 
where 0 = no pain and 10 = 
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Table 3. Number of Patients Presenting Pain During
Exercise on Each Postoperative Day
Day 1 Day 2 Day 3
Pain during deep expansive
breathing (n)




Pain during coughing (n)
1 3 3 2
2 12 14 7
* t
Pain during physiotherapy (n)
1 2 1 2
2 10 10 6
★ t
Group 1: high dose morphine; group 2: low dose morphine. 
*P < 0.05, V  < 0.01 (two-tailed Fisher's exact test),
no significant increase in PaC02 compared to the 
preoperative level of PaC02.
Hypercapnia (defined as a PaC02 higher than 52.5 
mm Hg) was observed in seven patients in group 1 
versus five patients in group 2 in the first postopera­
tive hour. The highest individual PaC02 1 hour after 
the operation was 63 (mm Hg) (group 1) versus 59.3 
(mm Hg) (group 2). The mean respiration rate was 
higher in group 1 at 1 hour after the operation. 
Thereafter, there was no difference in respiration rate 
between the two groups,
Side Effects
The incidence of side effects is listed in Table 4, A 
greater number of patients in group 2 had nausea, 
vomiting, and pruritus but this did not reach statisti­
cal significance.
Discussion
'Thoracotomy pain is generated from several 
sources, both during and after operation. These in­
clude soft tissue injury and inflammation, bone and 
joint trauma and visceral damage. Pain is exacer­
bated by movement especially by the obligatory 
movement of ventilation/ ' 1 Most important for post­
operative analgesia after thoracotomy is the possibil­
ity for activation, especially deep expansive breath­
ing, coughing, and physiotherapy.1,2'13
Continuous thoracic epidural analgesia with a 
combination of a local anesthetic and an opioid is 
the most effective method for postthoracotomy pain 
relief.2,5 Morphine appears to be an effective adju­
vant for thoracic epidural analgesia in combination 
with bupivacaine despite the possibility of late respi­
ratory depression, because of its water solu- 
bility.8,13'15
Since morphine is still the gold standard world 
wide, this study was designed to compare two doses 
of morphine in combination with bupivacaine by 
continuous thoracic epidural administration. The 
onset time of analgesia after epidural injection of 
morphine is delayed because of its hydrophylic char­
acter.7 Therefore morphine was injected immediately 
after evaluation of the test dose, followed by bupiva­
caine 0.5% with epinephrine.
Pain relief during rest was adequate in both 
groups. There was a difference between the two 
groups in favor of group 1, but this is clinically irrele­
vant because the VAS scores remained below 3 in 
both groups. This was also found by other investiga­
tors who administered epidural morphine in combi­
nation with bupivacaine after thoracotomy. But in
Fig. 2. Average values of post­
operative PaC02 (mm Hg) 
(±SEM) in both groups, plot­
ted against time (hours). No 
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Fig. 3. Respiration rate (min) 
(± SEM) after the operation in 
both groups, plotted against 
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these studies much more morphine was given epi- 
durally (0.3-1 mg/hr) with different concentrations 
of bupivacaine, but almost the same amount in milli­
grams.8'9,13
Our study is different from that of Logas et al.8 who 
employed 0.1 mg/mL morphine, 0.5% bupivacaine, 
and higher rates (3-6 mL/hr) of infusion. We 
showed that the use of higher concentrations of mor­
phine and bupivacaine at low rates of infusion re­
sulted in excellent pain relief after thoracotomy. This 
low rate of infusion should diminish cephalad spread 
of morphine, decreasing the risk of respiratory 
depression.
Pain relief during deep expansive breathing, 
coughing, and physiotherapy are the most important 
parameters of adequate analgesia. In only one previ­
ous study, postthoracotomy pain relief at rest and 
during exercise was investigated.13 In this study, 
Bigler et al. found no difference in postthoracotomy 
pain relief at rest and during exercise, although more 
than 50% of the patients in both groups needed sup­
plemental analgesia. 13 In our study, there was a dif­
ference in pain relief during deep expansive breath-









Group 1: high dose morphine; group 2 : low dose morphine. 
No statistical differences (two-tailed Fisher's exact test).
ing, coughing, and physiotherapy in favor of group
1. This adequate pain relief in group 1 is also illus­
trated by the fact that group 2 needed much more 
bolus doses during the 72 hours after the operation.
There was a difference in preoperative PaC02, but 
this is of no clinical importance. Furthermore, the 
difference in PaC02 between the two groups re­
mained during the postoperative period. The increase 
in PaC02 between the two groups on the first postop­
erative day was not significant. Conversely, the in­
crease in PaC02 in each group was significant. This 
appears to be a combined anesthetic surgical effect 
that is also seen in other studies.13,16 After the first 
day, the individual PaC02 returned to the preopera­
tive value in both groups.
During the 72 hours after the operation the respi­
ration rate remained normal without differences. In 
group 2 (0.1 mg/mL morphine) the incidence of pru­
ritus, nausea, and vomiting was higher than group
1 (0.2 mg/mL morphine). Because of this it is ques­
tionable if the side effects are solely due to morphine. 
The overall incidence of side effects was very low in 
both groups without any statistical differences.
Conclusion
The continuous high thoracic epidural administra­
tion of the combination of morphine and bupiva­
caine is an effective method for postthoracotomy 
pain relief. Pain relief during deep expansive breath­
ing, coughing, and physiotherapy was only adequate 
in group 1. No clinical significant ventilatory depres­
sion was demonstrated and no difference in the inci­
dence of side effects were found in both groups.
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Therefore, we conclude that 0.2 mg/mL morphine 
in bupivacaine 0.75% at an infusion rate of 0.8 mL/ 
hr, with a loading dose of 1 mg morphine epidurally, 
is a very effective dose for postthoracotomy pain re­
lief in rest and, more importantly, during exercise.
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